{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2009-Q-0301\" and posted_year = 2011 sorted by posted_date descending", "rows": [["FDA-2009-Q-0301-0032", "FDA", "FDA-2009-Q-0301", "FDA/CFSAN Office of Nutrition, Labeling, and Dietary Supplements to the Division of Dockets Management, June 27, 2011 - Letter", "Other", "Letter(s)", "2011-08-17T04:00:00Z", 2011, 8, "2011-08-17T04:00:00Z", null, "2011-08-17T17:39:26Z", null, 0, 0, "0900006480eb5f41"], ["FDA-2009-Q-0301-0027", "FDA", "FDA-2009-Q-0301", "FDA/CDER, Division of Pulmonary, Allergy and Rheumatology Products (DPARP) Medical Officer Consultation, April 11, 2011 - [Nestle Infant Nutrition/Gerber Products Company - Qualified Health Claim Petition] - Background Material", "Supporting & Related Material", "BKG-Background Material", "2011-06-09T04:00:00Z", 2011, 6, null, null, "2011-06-09T22:46:51Z", null, 0, 0, "0900006480e33fe2"], ["FDA-2009-Q-0301-0024", "FDA", "FDA-2009-Q-0301", "Consultation Between CDER DPARP and CFSAN on \"Most Common Disease....\", March 15, 2011 - [Nestle Infant Nutrition/Gerber Products Company - Qualified Health Claim Petition] - Background Material", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2011-06-09T04:00:00Z", 2011, 6, null, null, "2011-06-09T22:46:44Z", null, 0, 0, "0900006480e33f1e"], ["FDA-2009-Q-0301-0023", "FDA", "FDA-2009-Q-0301", "FDA/CDER Division of Dermatology and Dental Drug Products (DDDP), Medical Officer, Dermatology, Memorandum, April 21, 2010 - [Nestle Infant Nutrition/Gerber Products Company - Qualified Health Claim Petition] - Background Material", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2011-06-09T04:00:00Z", 2011, 6, null, null, "2011-06-09T22:46:42Z", null, 0, 0, "0900006480e33f1c"], ["FDA-2009-Q-0301-0022", "FDA", "FDA-2009-Q-0301", "FDA/CDER, Division of Pulmonary, Allergy and Rheumatology Products (DPARP) Medical Officer Consultation Final, April 5, 2010 - [Nestle Infant Nutrition/Gerber Products Company - Qualified Health Claim Petition] - Background Material", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2011-06-09T04:00:00Z", 2011, 6, null, null, "2011-06-09T22:46:40Z", null, 0, 0, "0900006480e33f1a"], ["FDA-2009-Q-0301-0025", "FDA", "FDA-2009-Q-0301", "FDA/CDER, Division of Pulmonary, Allergy and Rheumatology Products (DPARP) Medical Officer Consultation, March 14, 2010 - [Nestle Infant Nutrition/Gerber Products Company - Qualified Health Claim Petition] - Background Material", "Supporting & Related Material", "CP-Citizen Petition (Supporting & Related Materials)", "2011-06-09T04:00:00Z", 2011, 6, null, null, "2011-06-09T22:46:46Z", null, 0, 0, "0900006480e33fde"], ["FDA-2009-Q-0301-0028", "FDA", "FDA-2009-Q-0301", "FDA/CFSAN to the Division of Dockets Management re: Qualified Health Claim for 100% Whey-Protein Hydrolyzed Infant Formula and a Reduced Risk of Atopic Dermatitis, May 27 and May 25, 2011 - Letter", "Other", "LET-Letter", "2011-06-09T04:00:00Z", 2011, 6, "2011-06-09T04:00:00Z", null, "2013-07-27T23:55:27Z", null, 0, 0, "0900006480e439dd"], ["FDA-2009-Q-0301-0029", "FDA", "FDA-2009-Q-0301", "Enclosure 1 - \"Abbott Laboratories Comment to FDA/CFSAN/ONLDS\" - [FDA/CFSAN to the Division of Dockets Management re: Qualified Health Claim for 100% Whey-Protein Hydrolyzed Infant Formula and a Reduced Risk of Atopic Dermatitis, May 27 and May 25, 2011 - Letter] re FDA-2009-Q-0301-0028", "Supporting & Related Material", "LET-Letter (Supporting and Related Material)", "2011-06-09T04:00:00Z", 2011, 6, null, null, "2011-06-09T23:14:57Z", null, 0, 0, "0900006480e373e2"], ["FDA-2009-Q-0301-0026", "FDA", "FDA-2009-Q-0301", "Comment on Typographical Emphasis on an Infant Formula QHC, April 12, 2011 - [Nestle Infant Nutrition/Gerber Products Company - Qualified Health Claim Petition] - Background Material", "Supporting & Related Material", "BKG-Background Material", "2011-06-09T04:00:00Z", 2011, 6, null, null, "2011-06-09T22:46:49Z", null, 0, 0, "0900006480e33fe0"], ["FDA-2009-Q-0301-0031", "FDA", "FDA-2009-Q-0301", "Enclosure 3 - \"Toit, et al., Can Food Allergy be Prevented? The Current Evidence\" - [FDA/CFSAN to the Division of Dockets Management re: Qualified Health Claim for 100% Whey-Protein Hydrolyzed Infant Formula and a Reduced Risk of Atopic Dermatitis, May 27 and May 25, 2011 - Letter] re FDA-2009-Q-0301-0028", "Supporting & Related Material", null, "2011-06-09T00:00:00Z", 2011, 6, null, null, "2011-06-09T23:17:27Z", null, 0, 1, "0900006480e373e4"], ["FDA-2009-Q-0301-0030", "FDA", "FDA-2009-Q-0301", "Enclosure 2 - \"ASCIA Annual Scienific Meeting 2008 Abstracts\" - [FDA/CFSAN to the Division of Dockets Management re: Qualified Health Claim for 100% Whey-Protein Hydrolyzed Infant Formula and a Reduced Risk of Atopic Dermatitis, May 27 and May 25, 2011 - Letter] re FDA-2009-Q-0301-0028", "Supporting & Related Material", null, "2011-06-09T00:00:00Z", 2011, 6, null, null, "2011-06-09T23:17:53Z", null, 0, 1, "0900006480e373e3"], ["FDA-2009-Q-0301-0019", "FDA", "FDA-2009-Q-0301", "FDA/CFSAN to Regulatory Discretion, Inc - Letter", "Supporting & Related Material", "LET-Letter (Supporting and Related Material)", "2011-06-02T04:00:00Z", 2011, 6, null, null, "2016-10-31T15:03:11Z", null, 0, 0, "0900006480e39a5c"], ["FDA-2009-Q-0301-0020", "FDA", "FDA-2009-Q-0301", "FDA/CFSAN to the Division of Dockets Management re: Qualified Health Claim for 100% Whey-Protein Hydrolyzed Infant Formula and a Reduced Risk of Atopic Dermatitis, May 25, 2011 - Letter", "Other", "LET-Letter", "2011-06-02T04:00:00Z", 2011, 6, "2011-06-02T04:00:00Z", null, "2013-08-11T04:46:04Z", null, 0, 0, "0900006480e34a14"], ["FDA-2009-Q-0301-0018", "FDA", "FDA-2009-Q-0301", "Nestle Infant Nutrition to FDA/CFSAN, April 7, 2011 - Letter", "Other", "LET-Letter", "2011-05-18T04:00:00Z", 2011, 5, "2011-05-18T04:00:00Z", null, "2011-06-02T22:04:01Z", null, 0, 0, "0900006480d1e55c"], ["FDA-2009-Q-0301-0015", "FDA", "FDA-2009-Q-0301", "FDA/CFSAN Memorandum to the Division of Dockets Management, February 23, 2011 - Memorandum", "Other", "M-Memorandum", "2011-03-04T05:00:00Z", 2011, 3, "2011-03-04T05:00:00Z", null, "2013-08-11T03:13:23Z", null, 0, 0, "0900006480bfb3b3"], ["FDA-2009-Q-0301-0017", "FDA", "FDA-2009-Q-0301", "Enclosure 1 - \"...100% Whey-Protein Partially Hydrolyzed Infant Formula and Reduced Rist of Atopc Dermatitis\" - [Nestle Infant Nutrition to FDA/CFSAN, November 8, 2010 - Letter] re FDA-2009-Q-0301-0016", "Supporting & Related Material", "LET-Letter (Supporting and Related Material)", "2011-03-04T05:00:00Z", 2011, 3, null, null, "2011-03-05T00:13:07Z", null, 0, 0, "0900006480bfb3b5"]], "truncated": false, "filtered_table_rows_count": 16, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA-2009-Q-0301", "p1": "2011"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2009-Q-0301&posted_year=2011", "results": [{"value": "FDA", "label": "FDA", "count": 16, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-Q-0301&posted_year=2011&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2009-Q-0301&posted_year=2011", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 11, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-Q-0301&posted_year=2011&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 5, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-Q-0301&posted_year=2011&document_type=Other", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2009-Q-0301&posted_year=2011", "results": [{"value": 2011, "label": 2011, "count": 16, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-Q-0301", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-Q-0301&posted_year=2011&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-Q-0301&posted_year=2011&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-Q-0301&posted_year=2011&_facet=posted_month"}, {"name": "withdrawn", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-Q-0301&posted_year=2011&_facet=withdrawn"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-Q-0301&posted_year=2011&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-Q-0301&posted_year=2011&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-Q-0301&posted_year=2011&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 1406.7718859296292, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}